
Mελέτες που παρουσιάστηκαν:
– Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
– Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
– Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
– Semaglutide in Adults with Type 1 Diabetes and Obesity
Όλα τα Podcasts






